Difference between revisions of "Fibrinogen alpha chain (TG2)"
m (Fibrinogen alpha chain moved to Fibrinogen alpha chain (TG2)) |
|||
| Line 47: | Line 47: | ||
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| − | | | + | | |
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
Revision as of 07:50, 25 July 2007
| Template:Infobox header| Fibrinogen alpha chain (TG2) | |
|---|---|
| Fibrinogen alpha chain (TG2) | |
| Substrate peptide name | Fibrinogen alpha chain (TG2) |
| Synonyms | - |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Extracellular; plasma |
| Swissprot ID | P02671 |
| Reactive glutamines | Q328, Q366 |
| Reactive lysines | K148, K230, K303, K413 |
| Substrate sequence | GSTGNQNPGSP
SGSTGQWHSES QLVDMKRELVD VPPEWKALTDM GTATWKPGSSG EYHTEKLVTSK |
| Structure | 1LT9 |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:10816585 |
| Notes | |
| Template:Infobox header | | |